Clinical benefit of platinum doublet combination therapy in older adults with advanced non‐small cell lung cancer: A prospective multicenter study by the National Hospital Organization in Japan

BACKGROUND: Previous trials suggest that older adults with non‐small cell lung cancer (NSCLC) derive benefit from platinum doublet combination therapy, but its superiority is controversial. Although geriatric assessment variables are used to assess the individual risk of severe toxicity and clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimokawa, Mototsugu, Kanazu, Masaki, Saito, Ryusei, Mori, Masahide, Tamura, Atsuhisa, Okano, Yoshio, Fujita, Yuka, Endo, Takeo, Motegi, Mitsuru, Takata, Shohei, Kita, Toshiyuki, Sukoh, Noriaki, Mizuki, Fumitaka, Takenoyama, Mitsuhiro, Atagi, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260489/
https://www.ncbi.nlm.nih.gov/pubmed/37073452
http://dx.doi.org/10.1111/1759-7714.14904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260489/
https://www.ncbi.nlm.nih.gov/pubmed/37073452
http://dx.doi.org/10.1111/1759-7714.14904

Ejemplares similares